Key result
ET-1-induced constrictions are mediated by both ET(A) and ET(B) receptors in intrapulmonary arteries and by ET(A) in extrapulmonary arteries, suggesting pharmacological heterogeneity of ET(A).
This preclinical study demonstrates pharmacological heterogeneity in endothelin receptor-mediated vasoconstriction across different regions of the rat pulmonary vasculature.
Answers are grounded in this paper and cite their sources.
Rat pulmonary artery data should not alter ET antagonist use in patients; hypothesis-generating for regional receptor heterogeneity in human disease.
The endothelin (ET) receptors mediating rat pulmonary arterial constrictions were investigated. ET-1 and ET-3 constricted both isolated intrapulmonary artery (IPA) and extrapulmonary artery (EPA), with ET-1 having a potency approximately 10 times that of ET-3. The ET(B) selective agonist IRL-1620 produced constriction of only IPA. The ET(B) selective antagonist BQ-788 suppressed the ET-1-induced constriction of IPA only. The ET(A) selective antagonist BQ-123 more effectively antagonized the ET-1-induced constriction of EPA than that of IPA. The combination of BQ-123 and BQ-788 increased the antagonistic response to ET-1 in IPA but not in EPA. Then, large constriction remained in IPA and EPA. The receptor nonselective antagonist PD-145065 almost completely inhibited the ET-1-induced constriction of IPA and EPA. BQ-123 completely inhibited the ET-3-induced constriction of EPA; however, it partially suppressed that of IPA. The combination of BQ-123 and BQ-788 completely inhibited the ET-3-induced constriction of IPA. These results demonstrate that the ET-1-induced constrictions are mediated by both ET(A) and ET(B) in IPA and by ET(A) in EPA. Because of differences in sensitivity to ET receptor antagonists for ET-1- and ET-3-induced constrictions, pharmacological heterogeneity of ET(A) is suggested. Additionally, endothelial denudation affected the ET-3-induced constriction of EPA, but not of IPA, and it didn't affect the response to ET-1. This suggests that the vasodilatory effect of endothelium on ET-3-induced vasoconstrictions varies depending on pulmonary vascular regions.
No takes yet. Share an insight, caveat, or question.
Higashi et al. (1997) studied this question. Endothelin receptor agonists and antagonists was evaluated on Pulmonary arterial constriction. ET-1-induced constrictions are mediated by both ET(A) and ET(B) receptors in intrapulmonary arteries and by ET(A) in extrapulmonary arteries, suggesting pharmacological heterogeneity of ET(A).
Synapse has enriched 10 related papers. Consider them for comparative context: